Rules - 2010

COMBAT METHAMPHETAMINE EPIDEMIC ACT OF 2005 (CMEA)

• Removal of Thresholds for the List I Chemicals Pseudoephedrine and Phenylpropanolamine (July 7, 2010)
• Proposed Rule: Implementation of the Methamphetamine Production Prevention Act of 2008
  (March 23, 2010)
• Information on Foreign Chain of Distribution for Ephedrine, Pseudoephedrine, and Phenylpropanolamine (March 5, 2010)
• Registration Requirements for Importers and Manufacturers of Prescription Drug Products Containing Ephedrine, Pseudoephedrine, or Phenylpropanolamine (February 1, 2010)

CHEMICAL CONTROL ACTIONS

• Established Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2011 (December 20, 2010)
• Final Revised Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2010 (December 20, 2010)
• Additions to Listing of Exempt Chemical Mixtures (September 2, 2010)
• Exempt Chemical Mixtures Containing Gamma-Butyrolactone (June 29, 2010)
• Proposed Revised Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2010 (June 28, 2010)
• Chemical Mixtures Containing Listed Forms of Phosphorus and Change in Application Process (June 25, 2010)
• Proposed Rule: Control of Ergocristine, a Chemical Precursor Used in the Illicit Manufacture of Lysergic Acid Diethylamide, as a List I Chemical (February 24, 2010)

DRUG SCHEDULING ACTIONS

• Schedules of Controlled Substances: Placement of 5-Methoxy-N,N- Dimethyltryptamine into Schedule I of the Controlled Substances Act (December 20, 2010)
• Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I (November 24, 2010)
• Listing of Approved Drug Products Containing Dronabinol in Schedule III (November 1, 2010)
• Schedules of Controlled Substances: Placement of Propofol Into Schedule IV; Proposed Rule (October 27, 2010)
• Placement of 2,5-Dimethoxy-4- (n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act; Correction (August 6, 2010)
• Proposed Rule: Placement of 2,5-Dimethoxy-4- (n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act; Correction (August 6, 2010)
• Correction of Code of Federal Regulations: Removal of Temporary Listing of Benzylfentanyl and Thenylfentanyl as Controlled Substances (June 29, 2010)
• Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance (June 29, 2010)
• Proposed Rule:Schedules of Controlled Substances: Exempted Prescription Product; River Edge Pharmaceutical, Servira (March 30, 2010)
• Schedules of Controlled Substances: Placement of Carisoprodol Into Schedule IV; Announcement of Hearing (March 26,2010)
• Schedules of Controlled Substances; Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhalers Manufactured by Classic Pharmaceuticals, LLC (March 23, 2010)

ELECTRONIC PRESCRIPTIONS FOR CONTROLLED SUBSTANCES

• Interim Rule - Electronic Prescriptions for Controlled Substances(March 31, 2010)
  • PDF Format
  • Economic impact Analysis of the Interim Final Rule (PDF)
  • Risk Assessment for the Interim Final Rule (PDF)

GENERAL

• Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies (October 6, 2010)
• Proposed Rule: Voluntary Surrender of Certificate of Registration (June 7, 2010)
• Changes to and Consolidation of DEA Mailing Addresses (March 9, 2010)
• Redelegation of Functions; Delegation of Authority to Drug Enforcement Administration Official (February 1, 2010)

NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).